Evidence map›Paper›PMID 42325652›Full record

ArticleOpen forum infectious diseases2026

Maternal and Newborn Group B

Barbara A Pahud, Shabir A Madhi, Nicola P Klein, Bing Cai, Ingrid L Scully, Michelle Gaylord, Ye Feng, Han-Qing Jiang, Kena A Swanson, Annaliesa S Anderson and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Barbara A PahudPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0002-7629-0636
Nicola P KleinKaiser Permanente Vaccine Study Center, Oakland, California, USA.
Bing CaiPfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
Ingrid L ScullyPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Michelle GaylordPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Ye FengPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Han-Qing JiangPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Kena A SwansonPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.ORCID https://orcid.org/0000-0002-3389-8414
Annaliesa S AndersonPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Alejandra GurtmanPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.
Iona MunjalPfizer Vaccines, Pfizer Inc, Pearl River, NewYork, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This descriptive seroepidemiology study characterized group B Methods: Healthy US and South African ≥18-year-olds at ≥34 weeks of pregnancy were enrolled. Exploratory analyses evaluated GBS serotype-specific (Ia, Ib, II, III, IV, and V) anticapsular polysaccharide (CPS) immunoglobulin G (IgG) geometric mean concentrations (GMCs) before and at delivery and in cord blood; newborn-to-maternal transplacental transfer ratios were determined. Results: We enrolled 722 maternal (United States, n = 273; South Africa, n = 449) and 592 newborn participants (n = 251; n = 341). Maternal GBS anti-CPS IgG GMCs were similar before and at delivery. A trend for higher GMCs (serotypes Ia, Ib, II, and III) among South African compared with US maternal participants was seen. As in maternal participants, GMCs for serotypes Ia and III trended higher among South African compared with US newborns. Mean transplacental transfer ratios were higher for US newborn-maternal pairs compared with South African dyads. Transplacental transfer ratios for serotypes Ia and Ib were >1 for US pairs. Among US participants, there was a trend for higher transplacental transfer ratios among White versus Black participants. Maternal hypergammaglobulinemia (gamma globulin >1.35 g/dL) was observed in 23.8% of South African participants and in no US participants. Conclusions: Group B

Indexed as

epidemiologygroup B Streptococcusmaternalnewborntransplacental transfer

Identifiers

PMID42325652
PMCPMC13276872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.